Advaxis, a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases, this morning told investors that a conference call and live audio webcast has been scheduled for Wednesday, March 6, 2013. Starting at 5 p.m. ET, management will discuss the company’s 2013 business outlook, including progress with and plans for advancing its lead development program, expected clinical and corporate milestones for the year, and its momentum and continued plans for further strengthening its financial position.
The biotech will also provide an update on the timing of the data release from the second of three dose cohorts in Lm-LLO-E7-07, a randomized, single blind, placebo controlled Phase 2 dose escalation study assessing the safety and efficacy of ADXS-HPV for the treatment of cervical intraepithelial neoplasia (CIN) 2/3. In a prior release, Advaxis said it anticipated reporting this data earlier in the first quarter of 2013. However, data are still being collected and analyzed from some of the clinical trial sites, therefore the results from Cohort 2 will instead be announced early in the second quarter.
Those who wish to join the call should do so by dialing 800-688-0836 (U.S./Canada) or 617-614-4072 (international). When requested, interested parties should enter code 70014771. A live audio webcast can also be accessed via http://www.advaxis.com/news/events-presentations. An archived version will be available on the Web site for 30 days.
Investors can replay the call by telephone for seven days beginning at 8:00 p.m. ET on March 6, 2013. Access numbers for this replay are 888-286-8010 (U.S./Canada) and 617-801-6888 (international); participant code 55408167.
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment